M3T01
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for M3T01, covering 2025-07-10 to 2025-07-10. Get the full timeline:
Most recent: Clinical Trial Update: A Clinical Trial to Evaluate the Safety, Tolerability and Clinical Efficacy of M3T01 Monotherapy and in Combination With Pembrolizumab and Other Systemic Therapies [Phase 1]